How much is Mojocare worth in 2026?

Mojocare has a current valuation of N/A based on their Early Stage VC (Series A) round and secondary market data.

How much funding has Mojocare raised?

Mojocare has raised N/A in total funding across 1 funding rounds.

Mojocare

Pharmaceuticals

Current Valuation

N/A

As of August 1, 2022

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A)

$15.7M

Last Funding

Aug 2022

Funding date

Capital Efficiency

N/A

Valuation / Funding

Interested in buying or selling Mojocare shares?

Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 1, 2022	Early Stage VC (Series A)	$15.7M	N/A	-

Valuation Analysis

Current Valuation Metrics

Mojocare is currently valued at N/A as of August 1, 2022.

Explore More Data

Detailed analysis for Mojocare

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

See full funding history

What is Mojocare Worth in 2026?

Mojocare is a leading private company in the Pharmaceuticals sector. Track Mojocare's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Mojocare Valuation is Determined

Private company valuations like Mojocare's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.